- €1.02bn
- €2.28bn
- €178.01m
- 66
- 57
- 93
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 192 | 175 | 172 | 173 | 178 |
Cost of Revenue | |||||
Gross Profit | 179 | 147 | 160 | 166 | 171 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 66.8 | 51 | 68.7 | 67 | 92.2 |
Operating Profit | 125 | 124 | 103 | 106 | 85.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 100 | 99.9 | 69.6 | 50.1 | 45.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 96.9 | 97.8 | 68.8 | 49.4 | 45 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 90.3 | 85.8 | 62.2 | 43.1 | 53.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 90.3 | 85.8 | 62.2 | 43.1 | 53.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.02 | 0.707 | 0.666 | 0.436 | 0.572 |
Dividends per Share |